Comparing dedicated and designated models of integrating mental health into chronic disease care: study protocol for a cluster randomized controlled trial.

Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2006-

Delivery of Health Care, Integrated* ; Mental Health* ; Randomized Controlled Trials as Topic*; Chronic Disease/*therapy; Community Health Workers ; Cost-Benefit Analysis ; Counseling ; Data Analysis ; Humans ; Outcome Assessment, Health Care ; Sample Size

Background: In low- and middle-income countries (LMIC), it is uncertain whether a "dedicated" approach to integrating mental health care (wherein a community health worker (CHW) has the sole responsibility of delivering mental health care) or a "designated" approach (wherein a CHW provides this service in addition to usual responsibilities) is most effective and cost-effective. This study aims to compare the effectiveness and cost-effectiveness of these two models of service integration relative to treatment as usual (TAU) for improving mental health and chronic disease outcomes among patients with HIV or diabetes.
Methods/design: This is a cluster randomised trial. We will randomise 24 primary health care facilities in the Western Cape Province of South Africa to one of three study arms. Within each cluster, we will recruit 25 patients from HIV and 25 from diabetes services for a total sample of 1200 participants. Eligible patients will be aged 18 years or older, take medication for HIV or diabetes, and screen positive on the Alcohol Use Disorder Identification Test for hazardous/harmful alcohol use or depression on the Centre for Epidemiology Scale on Depression. Participants recruited in clinics assigned to the designated or dedicated approach will receive three sessions of motivational interviewing and problem-solving therapy, while those recruited at TAU-assigned clinics will be referred for further assessment. Participants will complete an interviewer-administered questionnaire at baseline, and at 6 and 12 months post-enrolment to assess change in self-reported outcomes. At these end points, we will test HIV RNA viral load for participants with HIV and HbA1c levels for participants with diabetes. Primary outcomes are reductions in self-reported hazardous/harmful alcohol use and risk of depression. Secondary outcomes are improvements in adherence to chronic disease treatment, biomarkers of chronic disease outcomes, and health-related quality of life. Mixed-effect linear regression models will model the effect of the interventions on primary and secondary outcomes. The cost-effectiveness of each approach will be assessed using incremental cost-effectiveness ratios.
Discussion: Study findings will guide decision-making around how best to integrate mental health counselling into chronic disease care in a LMIC setting.
Trial Registration: Pan African Clinical Trials Registry, Trial registration number: ACTR201610001825403 . Registered 17 October 2016.

Health Psychol. 2004 Sep;23(5):443-51. (PMID: 15367063)
Afr J Psychiatry (Johannesbg). 2012 Sep;15(5):346-51. (PMID: 23044889)
Glob Ment Health (Camb). 2017 Apr 18;4:e7. (PMID: 28596908)
Int J Psychol. 2017 Apr;52(2):154-162. (PMID: 26249118)
BMJ Open. 2013 May 28;3(5):null. (PMID: 23793683)
Subst Abuse Treat Prev Policy. 2015 Nov 14;10:46. (PMID: 26576946)
BMJ. 2013 Jan 09;346:e8501. (PMID: 23303891)
S Afr Med J. 2011 Sep 28;101(10):751-7. (PMID: 22272856)
AIDS Care. 2012;24(3):319-23. (PMID: 22273005)
S Afr Med J. 2015 Sep 21;105(8):642-7. (PMID: 26449692)
World Psychiatry. 2014 Oct;13(3):306-9. (PMID: 25273304)
Psychol Med. 2016 Apr;46(5):1079-90. (PMID: 26708017)
Soc Psychiatry Psychiatr Epidemiol. 2008 Nov;43(11):889-97. (PMID: 18677573)
HIV Clin Trials. 2004 Mar-Apr;5(2):74-9. (PMID: 15116282)
Adv Prev Med. 2012;2012:569153. (PMID: 23198159)
J Health Care Poor Underserved. 2014 Nov;25(4):1723-9. (PMID: 25418238)
J Rural Health. 2018 Dec;34(1):48-62. (PMID: 28084667)
Soc Sci Med. 1991;32(6):705-14. (PMID: 2035047)
AIDS Care. 2000 Jun;12(3):255-66. (PMID: 10928201)
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003318. (PMID: 16625576)
Addict Behav. 2014 Jan;39(1):122-6. (PMID: 24090621)
Soc Psychiatry Psychiatr Epidemiol. 2015 Mar;50(3):461-8. (PMID: 25096982)
AIDS Care. 2017 Feb;29(2):209-213. (PMID: 27435957)
Lancet Psychiatry. 2015 Dec;2(12 ):1052-4. (PMID: 26613844)
PLoS Med. 2012 Feb;9(2):e1001178. (PMID: 22389632)
BMC Public Health. 2013 Jul 31;13:699. (PMID: 23902931)
J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S123-7. (PMID: 12562034)
Health Policy Plan. 2017 Jun 1;32(5):699-709. (PMID: 28369396)
PLoS Med. 2016 Nov 22;13(11):e1002178. (PMID: 27875542)
Br J Psychiatry. 2008 Feb;192(2):112-7. (PMID: 18245026)
PLoS Med. 2013;10(5):e1001448. (PMID: 23737736)
Addict Behav. 2012 Jan;37(1):36-41. (PMID: 21937169)
PLoS Med. 2013;10(5):e1001443. (PMID: 23690753)
Am J Psychiatry. 2011 Dec;168(12):1266-77. (PMID: 22193671)
J Clin Epidemiol. 2004 Aug;57(8):785-94. (PMID: 15485730)
S Afr Med J. 2007 Jun;97(6):438, 440. (PMID: 17691472)
Int J Inj Contr Saf Promot. 2014;21(3):236-43. (PMID: 23837749)
Lancet. 2013 Nov 9;382(9904):1575-86. (PMID: 23993280)
Lancet. 2016 Oct 8;388(10053):1459-1544. (PMID: 27733281)
Addict Behav. 2003 Jun;28(4):627-42. (PMID: 12726780)
Addiction. 2014 Mar;109(3):394-406. (PMID: 24304463)
Br J Psychiatry. 2012 Dec;201(6):444-50. (PMID: 23137730)
Hum Resour Health. 2016 Oct 26;14 (1):65. (PMID: 27784298)
Int J Drug Policy. 2016 Apr;30:52-8. (PMID: 26797188)
Glob Heart. 2014 Dec;9(4):431-43. (PMID: 25592798)
Afr J Psychiatry (Johannesbg). 2012 May;15(3):168-71. (PMID: 22722723)
J Psychol. 2005 Sep;139(5):439-57. (PMID: 16285214)
AIDS Care. 2010 Dec;22(12):1517-21. (PMID: 20824550)
Int Rev Psychiatry. 2010;22(6):599-610. (PMID: 21226648)
Cochrane Database Syst Rev. 2013 Nov 19;(11):CD009149. (PMID: 24249541)
Soc Sci Med. 2014 Oct;118:33-42. (PMID: 25089962)
J Health Psychol. 2018 Mar;23 (4):618-628. (PMID: 27091759)
Clin Psychol Rev. 2007 Jan;27(1):46-57. (PMID: 16480801)
Soc Sci Med. 2013 Nov;97:82-6. (PMID: 24161092)
BMC Health Serv Res. 2015 Jun 21;15:242. (PMID: 26094025)
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):393-404. (PMID: 19506789)
Age Ageing. 2015 May;44(3):397-403. (PMID: 25548124)
Diabetes Educ. 2007 Nov-Dec;33(6):1032-50; discussion 1051-2. (PMID: 18057272)
Patient Educ Couns. 2016 Oct;99(10 ):1558-67. (PMID: 27036083)
BMC Med. 2015 Apr 10;13:79. (PMID: 25879831)
Curr Opin Psychiatry. 2011 Jul;24(4):318-23. (PMID: 21546837)
AIDS Care. 2009 Sep;21(9):1163-8. (PMID: 20024776)
BMC Psychiatry. 2016 Feb 20;16:35. (PMID: 26897614)
Cost Eff Resour Alloc. 2006 Dec 06;4:20. (PMID: 17147833)
AIDS Care. 2006 Oct;18(7):853-61. (PMID: 16971298)

United Kingdom WT_ Wellcome Trust; MR/M014290/1 United Kingdom MRC_ Medical Research Council

Keywords: Chronic disease care; Common mental disorders; Integrated treatment; South Africa

Date Created: 20180318 Date Completed: 20190322 Latest Revision: 20230816

20231215

PMC5857135

10.1186/s13063-018-2568-9

29548302